维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="Ottmann OG"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia显示文摘	Ottmann OG Wassmann B	2005	Hematology Am Soc Hematol Edue Program2005，21，2：	1
2	Imatinib compared with chemotherapy as frontline treatment of elderly patients with Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ALL) 显示文摘	Ottmann OG Wassmann B Pfeifer H	2007	Cancer2007，109，10：	1
3	Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastie leukemia who failed imatinib:results from a phase 3 study显示文摘	Lilly MB Ottmann OG Shah NP	2010	Am J Haematol2010，85，3：	1
4	A randomized,double-blind,placebo controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia显示文摘	OTTMANN OG LIU-YAN JA	1999	Blood1999，94，：	1
5	Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL) 显示文摘	Ottmann OG Wassmann B Pfeifer H	2007	Cancer2007，109，10：	1
6	Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL) 显示文摘	Ottmann OG Wassmann B Pfeifer H	2007	Cancer2007，109，10：	1
7	Standardized MRD quantification in European ALL trials : proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008 显示文摘	Bruggemann M Schrauder A Raft T Pfeifer H Dworzak M Ottmann OG	2010	I eukemia2010，24，3：	1
8	Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)显示文摘	Ottmann OG Wassmann B Pfeifer H	2007	Cancer2007，109，10：	1
9	Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph +ALL) 显示文摘	Ottmann OG Wassmann B Pfeifer H	2007	Cancer2007，109，10：	1
10	Nilolinib(formerlyAMN107), a high selective BCR-ABL tyrosine kinase inhibitor, is active in patients with iraatinib-resistant orintolerant accelerated phase chronic myelogenous leukemia 显示文摘	Le Coutre P Ottmann OG Giles F	2008	Blood2008，111，4：	1
11	The DAC system and associa- tions with acute leukemias and myelodysplastic syn- dromes 显示文摘	Bug G Ottmann OG	2010	Invest New Drugs2010，28，1：	1
12	Imatinib compared with chem- otherapy as front-line treatment of elderly patients with Philadelphia chro-mosome-positive acute lymphoblastic leukemia ( Ph + ALL ) 显示文摘	Ottmann OG Wassmann B Pfeifer H	2007	Cancer2007，109，10：	1
13	Aphase 2 study of imatinib in patients with redaped or refrcctory philadephia chromosbme-positive acute lymphoid leakemia显示文摘	Druker BJ Sewyers CL	2002	Blood2002，100，16：	1
14	Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia 显示文摘	Ottmann OG Larson RA Kantarjian HM	2013	Leu- kemia2013，27，6：	1
15	Management of Philadelphia chromosome- positive acute lymphoblastic leukemia(Ph+ALL)显示文摘	Ottmann OG Pfeifer H	2009	Hematology Am Soc Hematol Educ Program2009，25，3：	1
16	First-line treatment of philadelphia chromosome-positive acute lymphoblastic leukemia in adults显示文摘	Ottmann OG Pfeifer H	2009	Curr Opin Oncol2009，21，1：	1
17	Quantification of human interleukin-18 mRNA expression by competitive reverse transcriptase polymerase chain reaction显示文摘	Klein SA Ottmann OG Ballas K	1999	Cytokine1999，11，6：	1
18	Targeting the phosphoinositide 3-kinase pathway in hematologic malig- nancies显示文摘	Jabbour E Ottmann OG Deininger M	2014	Haematologica2014，99，1：	1
19	A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemia显示文摘	Ottmann OG Druker BJ Sawyers CL	2002	Blood2002，100，6：	1
20	Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia显示文摘	Ottmann OG Larson RA Kantarjian HM	2013	Leukemia2013，27，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示